The Butantan Institute detected for the first time in Brazil the subline BN.1 of the Ômicron variant of the coronavirus. The sample was collected on October 27 from a 38-year-old woman living in the city of São Paulo.
The institute note reports that underlining was “first described in the Pango system of SARS-CoV-2 lineages in India” on July 28.
Currently, the highest incidence of this subline occurs in the United States (16% of all BN.1 samples found in the world), the United Kingdom (15%), Austria (14%), Australia (14%) and India (11 %).
Butantan specialists point out, however, that it is not a variant of concern, that is, it is not monitored by the World Health Organization and “should not cause a great impact”.
They add that there are several new variants in circulation in the state of São Paulo, but they are not strong enough to override BQ.1.1.
Anvisa expands the use and sale of medicines
The National Health Surveillance Agency (Anvisa) approved, this Monday (21), the pediatric use of Remdesivir against Covid-19. The publication confirming the expansion will be published in an extra edition of the Official Gazette.
As defined by the Agency, “infants and children from 28 days old and weighing 3 kg or more, with pneumonia that require supplemental oxygen administration (low- or high-flow oxygen, or other non-invasive ventilation in the initiation of treatment).
Another group contemplated is that of children weighing less than 40 kg who do not need supplemental oxygen, but who are at greater risk of developing the severe form of the disease.
Another approval made by Anvisa this Monday (21) was the sale of Paxlovid, a drug for the treatment of Covid-19 for adults, in pharmacies and private hospitals. Purchases can only be made with a prescription.
Thus, the supply of the drug to the private market is authorised, with the labeling and leaflet in Portuguese from Portugal and in Spanish. The Agency highlighted, however, that the manufacturer must maintain and prioritize the supply of the Unified Health System (SUS).
The approval took place unanimously by the collegiate board of the body, which also confirmed the extension of the validity of the medicine from 12 months to 18 months.
Understand how Paxlovid works in the treatment of Covid-19.
*with information from the Butantan Portal
Source: CNN Brasil
I am an experienced journalist and writer with a career in the news industry. My focus is on covering Top News stories for World Stock Market, where I provide comprehensive analysis and commentary on markets around the world. I have expertise in writing both long-form articles and shorter pieces that deliver timely, relevant updates to readers.
